The short version of lyophilisation fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Claims about enhanced focus, memory, or mood in healthy people rest mostly on anecdotal reports and community discussion rather than on controlled data. It remains unclear whether any cognitive benefit observed in patients recovering from brain injury would extend to uninjured users. Dose-response relationships, long-term safety, and interactions with other drugs are not well characterized in the peer-reviewed literature. Questions about optimal route of administration and treatment duration likewise remain open.
Semax binds to melanocortin receptors and is thought to influence neuronal survival and plasticity rather than to act through the adrenal axis. Laboratory work has shown increased expression of brain-derived neurotrophic factor and nerve growth factor in treated tissue. Changes in c-Fos, a marker of neuronal activation, have also been reported. Because the peptide is rapidly degraded by peptidases, its effects are generally attributed to downstream signaling cascades rather than to sustained receptor occupancy.
Published studies are dominated by animal models of stroke, ischemia, and cognitive impairment, with a smaller number of human trials conducted in Russia. Many of the human reports are small, single-center, and published in Russian-language journals, which limits independent scrutiny. Outcome measures vary between studies and often rely on clinician-rated scales rather than objective biomarkers. Systematic reviews have noted the methodological weaknesses and called for larger, preregistered trials before firm conclusions can be drawn.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
Semax is a synthetic seven-amino-acid peptide whose sequence extends the ACTH(4-10) fragment with a C-terminal proline-glycine-proline tripeptide. The commonly cited sequence is Met-Glu-His-Phe-Pro-Gly-Pro, giving a molecular formula near C37H51N9O10S and a molecular weight close to 813.9 g/mol. It belongs to the broader class of synthetic ACTH fragments studied for central nervous system effects rather than for adrenal steroid stimulation. In practice the material appears as a lyophilized white powder for laboratory work or as a dilute saline solution in clinical settings.
| Property | Value | Notes |
|---|---|---|
| Appearance | White lyophilized powder | Typical for synthetic peptides |
| Solubility | Freely soluble in water | Also soluble in saline |
| Storage temperature | -20 C or below | Protect from repeated freeze-thaw |
| Analytical method | Reverse-phase HPLC | Confirms purity and identity |
| Common synonym | ACTH(4-10) analog | Reflects structural origin |
Identity and purity of semax are established with reversed-phase high-performance liquid chromatography coupled to ultraviolet detection, usually at 214 nanometres. Mass spectrometry, most often electrospray ionisation in positive mode, confirms the molecular mass and reveals truncated sequences. Amino acid analysis and peptide mapping after enzymatic digestion provide additional structural confirmation. Laboratories typically report purity as the percentage area of the main peak, a figure that does not capture isomeric or oxidised variants unless the method resolves them.
The peptide is prone to several degradation pathways. Oxidation of the methionine residue produces a sulfoxide that elutes close to the parent peak in many chromatographic systems. Hydrolysis of peptide bonds and deamidation of susceptible residues in related sequences also reduce purity over time. Lyophilised material kept dry at minus twenty degrees Celsius and shielded from light is the most stable form commonly described in laboratory practice.
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.
Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.
Lyophilised powder is normally kept at -20 °C in a desiccated container, with some suppliers recommending -80 °C for long-term archival storage. Repeated freeze-thaw cycles are the most common cause of avoidable loss, so aliquoting before freezing reduces variability between working sessions. Dissolved peptide is far less stable than the dry solid and is usually prepared fresh or held briefly at 4 °C. Aqueous solutions support both hydrolysis of the backbone and oxidation of the N-terminal methionine, and these two routes dominate degradation under ordinary laboratory conditions.
Identity and purity are confirmed with reversed-phase high-performance liquid chromatography, typically monitored at 214 nanometres where the peptide bond absorbs. Mass spectrometry, either electrospray or MALDI-TOF, verifies molecular mass against the theoretical value and detects truncation or adduct formation. Amino acid analysis and peptide mapping provide additional confirmation when required. The most frequently reported impurities are deletion sequences from incomplete coupling, methionine sulfoxide from oxidation, and dimeric species formed through non-covalent aggregation. Impurity profiles depend strongly on the synthesis and purification route chosen by the producer.
Published research has focused mainly on neurological and cognitive endpoints in animal models, with proposed mechanisms involving brain-derived neurotrophic factor and related signalling pathways. A substantial share of the human data originates from a limited number of research groups, and independent replication in other countries remains sparse. Regulatory status reflects that distribution: the peptide is registered as a medicine in Russia and appears in some neighbouring markets, while elsewhere it is handled as a research chemical without approved therapeutic labelling. Questions about dose-response relationships, long-term effects, and comparability across studies are still open.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
== Essentiality in humans == Of the twenty amino acids common to all life forms (not counting selenocysteine), humans cannot synthesize nine: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine. Additionally, the amino acids arginine, cysteine, glutamine, glycine, proline and tyrosine are considered conditionally essential, which means that specific populations who do not synthesize it in adequate amounts, such as newborn infants and people with diseased livers who are unable to synthesize cysteine, must obtain one or more of these conditionally essential amino acids from their diet. For example, enough arginine is synthesized by the urea cycle to meet the needs of an adult but perhaps not those of a growing child. Amino acids that must be obtained from the diet are called essential amino acids. Eukaryotes can synthesize some of the amino acids from other substrates. Consequently, only a subset of the amino acids used in protein synthesis are essential nutrients.
=== Black Consciousness and empowerment === Biko rejected the apartheid government's division of South Africa's population into "whites" and "non-whites", a distinction that was marked on signs and buildings throughout the country. Building on Fanon's work, Biko regarded "non-white" as a negative category, defining people in terms of an absence of whiteness. In response, Biko replaced "non-white" with the category "black", which he regarded as being neither derivative nor negative. He defined blackness as a "mental attitude" rather than a "matter of pigmentation", referring to "blacks" as "those who are by law or tradition politically, economically and socially discriminated against as a group in the South African society" and who identify "themselves as a unit in the struggle towards the realization of their aspirations". In this way, he and the Black Consciousness Movement used "black" in reference not only to Bantu-speaking Africans but also to Coloureds and Indians, who together made up almost 90% of South Africa's population in the 1970s. Biko was not a Marxist and believed that it was oppression based on race, rather than class, which would be the main political motivation for change in South Africa. He argued that those on the "white left" often promoted a class-based analysis as a "defence mechanism... primarily because they want to detach us from anything relating to race. In case it has a rebound effect on them because they are white".
Pre-exposure to the antigens present in vaccines elicits a primary response. After injection, antigens will be ingested by antigen-presenting cells (APCs), such as dendritic cells and macrophages, via phagocytosis. The APCs will travel to lymph nodes, where immature B cells and T cells are present. Following antigen processes by APCs, antigens will bind to either MHC class I receptors or MHC class II receptors on the cell surface of the cells based on their compositional and structural features to form complexes. Antigen presentation occurs, in which T cell receptors attach to the antigen-MHC complexes, initiating clonal expansion and differentiation, and hence the conversion of naive T cells to cytotoxic T cells (CD8+) or helper T cells (CD4+). Cytotoxic CD8+ cells can directly destroy the infected cells containing the antigens that were presented to them by the APCs by releasing lytic molecules, while helper CD4+ cells are responsible for the secretion of cytokines that activates B cells and cytotoxic T cells. B cells can undergo activation in the absence of T cells via the B cell receptor signalling pathway. After dendritic cells capture the immunogen present in the vaccine, they can present the substances to naive B cells, causing the proliferation of plasma cells for antibody production. Isotype switching can take place during B cell development for the formation of different antibodies, including IgG, IgE and IgA. Memory B cells and T cells are formed post-infection.
== Technology overview == In analytical chromatography, the goal is to separate and uniquely identify each of the compounds in a substance. Alternatively, preparative scale chromatography is a method of purification of large batches of material in a production environment. The basic methods of separation in HPLC rely on a mobile phase (water, organic solvents, etc.) being passed through a stationary phase (particulate silica packings, monoliths, etc.) in a closed environment (column); the differences in reactivity among the solvent of interest and the mobile and stationary phases distinguish compounds from one another in a series of adsorption and desorption phenomena. The results are then visually displayed in a resulting chromatogram. Stationary phases are available in many varieties of packing styles as well as chemical structures and can be functionalized for added specificity. Monolithic-style columns, or monoliths, are one of many types of stationary phase structure. Monoliths, in chromatographic terms, are porous rod structures characterized by mesopores and macropores. These pores provide monoliths with high permeability, a large number of channels, and a high surface area available for reactivity. The backbone of a monolithic column is composed of either an organic or inorganic substrate in, and can easily be chemically altered for specific applications. Their unique structure gives them several physico-mechanical properties that enable them to perform competitively against traditionally packed columns.
Sources: en.wikipedia.org
{\displaystyle {\begin{aligned}u_{x}&={\frac {4{\sqrt {2}}}{3{\sqrt {3}}}}\,U_{0}\left[\,\sin \left(kx-{\frac {\pi }{3}}\right)\cos \left(ky+{\frac {\pi }{3}}\right)\sin \left(kz+{\frac {\pi }{2}}\right)-\cos \left(kz-{\frac {\pi }{3}}\right)\sin \left(kx+{\frac {\pi }{3}}\right)\sin \left(ky+{\frac {\pi }{2}}\right)\,\right]e^{-3\nu k^{2}t}\\u_{y}&={\frac {4{\sqrt {2}}}{3{\sqrt {3}}}}\,U_{0}\left[\,\sin \left(ky-{\frac {\pi }{3}}\right)\cos \left(kz+{\frac {\pi }{3}}\right)\sin \left(kx+{\frac {\pi }{2}}\right)-\cos \left(kx-{\frac {\pi }{3}}\right)\sin \left(ky+{\frac {\pi }{3}}\right)\sin \left(kz+{\frac {\pi }{2}}\right)\,\right]e^{-3\nu k^{2}t}\\u_{z}&={\frac {4{\sqrt {2}}}{3{\sqrt {3}}}}\,U_{0}\left[\,\sin \left(kz-{\frac {\pi }{3}}\right)\cos \left(kx+{\frac {\pi }{3}}\right)\sin \left(ky+{\frac {\pi }{2}}\right)-\cos \left(ky-{\frac {\pi }{3}}\right)\sin \left(kz+{\frac {\pi }{3}}\right)\sin \left(kx+{\frac {\pi }{2}}\right)\,\right]e^{-3\nu k^{2}t}\end{aligned}}}
Denmark: The Minister for Foreign Affairs said: "I expect the UN Security Council to meet quickly to discuss the situation – we need to get back on track towards de-escalation and dialogue," adding "we must maintain respect for the international rules of the game". France: President Emmanuel Macron called for Maduro's 2024 opposition candidate, Edmundo González, whom he refers to as "president", to oversee a "peaceful, democratic" transition. Macron praised the removal of the "Maduro dictatorship," stating that the Venezuelan people "can only rejoice" at being rid of his rule. Foreign Minister Jean-Noël Barrot criticized the U.S. military action that deposed Maduro, arguing that it contravened international law. He stated that the use of force violated the principle of non-resort to force and emphasized that France does not believe a durable political solution can be imposed from outside the country, reaffirming that a nation's future must be decided by its own people. Georgia: The Ministry of Foreign Affairs stated that it was "closely following" the situation in Venezuela "with the hope that future processes will unfold in line with the best interests of the Venezuelan people", and expressed its hopes that Venezuela would revoke its recognition of Abkhazia and South Ossetia. Germany: Chancellor Friedrich Merz stated that "Nicolás Maduro has led his country into ruin. The most recent election was rigged. Like many other countries, we have therefore not recognized his presidency. Maduro has played a problematic role in the region. The legal assessment of the U.S.
American cockroaches have three developmental stages: egg, nymph, and adult. Females produce an egg case (ootheca) which protrudes from the tip of the abdomen. On average, females produce 9–10 oothecae, although they can sometimes produce as many as 90. After about two days, the egg cases are placed on a surface in a safe location. Egg cases are about 0.9 cm (0.35 in) long, brown, and purse-shaped. Immature cockroaches emerge from egg cases in 6–8 weeks and require 6–12 months to mature. After hatching, the nymphs feed and undergo a series of 13 moultings (or ecdysis). Adult cockroaches can live up to an additional year, during which females produce an average of 150 young. The American cockroach reproductive cycle can last up to 600 days.
Sources: en.wikipedia.org
It is associated with the melanocortin receptor family, particularly subtypes found in the central nervous system. This interaction is separate from the adrenal pathway activated by full-length ACTH.
Peptidases degrade the compound within minutes in circulation. This short half-life is one reason nasal delivery is used, placing the substance close to the olfactory and trigeminal pathways.
No large multicenter trials have been published in English-language journals. The existing human evidence consists mainly of smaller studies conducted in Russia, which limits generalization.
It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.